Ameriprise
AVIR icon

Ameriprise’s Atea Pharmaceuticals AVIR Stock Holding History

Ameriprise’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,618
Closed -$65.6K – 4085
2025
Q3 		$65.6K Sell
22,618
-11,133
-33% -$38K ﹤0.01% 4004
2025
Q2 		$122K Hold
33,751
– – ﹤0.01% 3870
2025
Q1 		$101K Sell
33,751
-52,418
-61% -$164K ﹤0.01% 3879
2024
Q4 		$289K Sell
86,169
-11,900
-12% -$39.5K ﹤0.01% 3742
2024
Q3 		$329K Sell
98,069
-3,724
-4% -$13.5K ﹤0.01% 3615
2024
Q2 		$337K Sell
101,793
-4,025
-4% -$15K ﹤0.01% 3556
2024
Q1 		$428K Buy
105,818
+52,329
+98% +$205K ﹤0.01% 3468
2023
Q4 		$163K Buy
53,489
+11,601
+28% +$35.1K ﹤0.01% 3749
2023
Q3 		$126K Sell
41,888
-7,240
-15% -$24.6K ﹤0.01% 3767
2023
Q2 		$184K Buy
49,128
+5,825
+13% +$21.8K ﹤0.01% 3744
2023
Q1 		$145K Buy
43,303
+20,343
+89% +$82.5K ﹤0.01% 3790
2022
Q4 		$111K Sell
22,960
-5
-0% -$25 ﹤0.01% 3800
2022
Q3 		$131K Buy
+22,965
New +$176K ﹤0.01% 3777
2021
Q4 		– Sell
-25,266
Closed -$885K – 3960
2021
Q3 		$885K Buy
+25,266
New +$701K ﹤0.01% 3214
2021
Q2 		– Sell
-62,365
Closed -$3.85M – 3893
2021
Q1 		$3.85M Sell
62,365
-48,811
-44% -$3.3M ﹤0.01% 2544
2020
Q4 		$4.64M Buy
+111,176
New +$3.58M ﹤0.01% 2324

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise's AVIR Position: Q4 2025 in Review

Ameriprise sold out of Atea Pharmaceuticals (AVIR) in Q4 2025, closing a stake of 22,618 shares — an estimated $65.6K sold.

Ameriprise first reported a position in AVIR in Q4 2020 and held it in 16 quarters. The position peaked at $4.64M in Q4 2020. 111 funds tracked by Wall St. Rank hold AVIR as of Q4 2025.

  • Ameriprise reported no remaining Atea Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Ameriprise sold 22,618 Atea Pharmaceuticals shares in Q4 2025, an estimated $65.6K.
  • Ameriprise first reported a position in Atea Pharmaceuticals in Q4 2020 and held it in 16 quarters.
  • Ameriprise's Atea Pharmaceuticals position peaked at $4.64M in Q4 2020.
  • 111 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q4 2025.

Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.